1. Home
  2. XFOR vs LAB Comparison

XFOR vs LAB Comparison

Compare XFOR & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo X4 Pharmaceuticals Inc.

XFOR

X4 Pharmaceuticals Inc.

N/A

Current Price

$3.01

Market Cap

318.6M

Sector

Health Care

ML Signal

N/A

Logo Standard BioTools Inc.

LAB

Standard BioTools Inc.

N/A

Current Price

$0.60

Market Cap

257.2M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
XFOR
LAB
Founded
2014
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Laboratory Analytical Instruments
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
318.6M
257.2M
IPO Year
2017
2008

Fundamental Metrics

Financial Performance
Metric
XFOR
LAB
Price
$3.01
$0.60
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
★ $11.60
N/A
AVG Volume (30 Days)
739.5K
★ 990.0K
Earning Date
11-04-2026
12-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 61.54
EPS
N/A
★ 0.29
Revenue
$6,500,000.00
★ $101,937,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$2.17
Revenue Growth
★ 150.00
N/A
52 Week Low
$2.43
$0.39
52 Week High
$4.83
$1.72

Technical Indicators

Market Signals
Indicator
XFOR
LAB
Relative Strength Index (RSI) 45.77 44.99
Support Level $2.86 N/A
Resistance Level $4.49 $0.77
Average True Range (ATR) 0.25 0.07
MACD -0.03 -0.00
Stochastic Oscillator 32.61 58.65

Price Performance

Historical Comparison
XFOR
LAB

About XFOR X4 Pharmaceuticals Inc.

X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare hematology diseases. The Company's clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.

About LAB Standard BioTools Inc.

Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.

Share on Social Networks: